ChromaCode, Inc.

ChromaCode is a molecular diagnostics company with a bioinformatics focus.

[ChromaCode, Inc. @chromacodeinc]

Attending @PMWCintl? Don’t miss the presentation by our CBO, Padma Sundar, who is speaking about using our #HDPCR assay for high TAM applications which might otherwise require #NGS, as part of the Showcase Track S2: Clinical Dx/Tools Track.

https://t.co/xIcmkhyh39

#PMWC24

[ChromaCode, Inc. @chromacodeinc]

In this story in @Tech_Networks originally by @UCDavis, Innovative blood tests can spot cancer 18 months before CT scans, highlighting the value of technologies such as ChromaCode develops.

For more: https://t.co/Or35tzBNyT

#HealthTech #HealthInnovation

[ChromaCode, Inc. @chromacodeinc]

🧬 Genetic testing for cancer risk is becoming more affordable, thanks to firms like ChromaCode. Learn how advancements in genetic screening, as reported by @NPR's Nell Greenfieldboyce, are saving lives. https://t.co/CJNd8iBMmB

#GeneticTesting

[ChromaCode, Inc. @chromacodeinc]

In the continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough highlight @ChromaCodeInc’s pivotal role in enhancing investor confidence.

#Biotech #Innovation #JPM2024 #Genomics

https://t.co/g2xjilM0zK

[Russo Partners @russopartners]

Mark McDonough of @chromacodeinc: Driving investor confidence with innovative organ transplant diagnostics in 2024. Their tech aims to revolutionize testing, boosting #BioTech investment through strategic partnerships.

#HealthTech #InvestorConfidence

[ChromaCode, Inc. @chromacodeinc]

#ICYMI: Mark McDonough of @ChromaCodeInc discusses the game changing HDPCR tech with @MedDevNTech. By bridging the gap in genomics, ChromaCode strives to deliver cost-effective solutions that more quickly deliver results.

For more: https://t.co/mbEZi1FYUP

#HealthTech #Genomics

[ChromaCode, Inc. @chromacodeinc]

🎧 Listen to the @Medtech_Insight podcast featuring @ChromaCodeInc's Mark McDonough, discussing the innovative genomic solutions they're developing to facilitate targeted treatment of cancer.

More here: https://t.co/pW73jUfZ2M

#HealthcareInnovation #Cancer

[ChromaCode, Inc. @chromacodeinc]

First in Human podcast by Vial features Mark McDonough of @ChromaCodeInc on the impact of early detection on disease outcomes. From military to Chairman & CEO, hear how he's leading change in genomics. https://t.co/Q7W5XRcbER

#Innovation #Genomics

[ChromaCode, Inc. @chromacodeinc]

In this continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough on @ChromaCodeInc’s growth discipline in today’s challenging environment.

#Biotech #Innovation #JPM2024 #Genomics

https://t.co/YV8mDvLgzd

[Russo Partners @russopartners]

Mark McDonough of @ChromaCode discusses the importance of growth discipline in #BioTech on "Conversations Life Science Leaders Aren't Having" with @jeffdharmon74. Post- #JPM2024, Mark emphasizes innovation and being good stewards of capital. #HealthcareInnovation #Resilience

[ChromaCode, Inc. @chromacodeinc]

Did you know our cloud analysis platform recently got an upgrade? ChromaCode Cloud 6.1 represents a significant leap forward in our commitment to enhancing our cutting-edge #genomics solutions.

https://t.co/WxjCQGKnLB

#dPCR #Oncology #Innovation

[ChromaCode, Inc. @chromacodeinc]

#MeetTheTeam – Brett Brown, our VP of Finance and Administration, has over twenty years of experience in finance, corporate management, and human resources.

https://t.co/aHdBgUBQAK

#genetics #oncology #leadership #dPCR

[ChromaCode, Inc. @chromacodeinc]

It was great seeing everyone at @PMWCintl! We had an excellent time speaking with our colleagues in the #precisionmedicine space. Special thanks to everyone who came to our workshop and made it successful!

#Oncology #Genomics #dPCR

[ChromaCode, Inc. @chromacodeinc]

Today is #WorldCancerDay, a day to recognize the high toll that cancer takes around the world.

Because of a lack of accessibility, many people around the world aren’t able to receive the most effective cancer treatments.

https://t.co/xk1KVPYrDk

#CloseTheCareGap @worldcancerday

[ChromaCode, Inc. @chromacodeinc]

#ICYMI – Mark McDonough, ChromaCode’s CEO, was recently featured on @mydocwire, where he spoke about our #HDPCR technology and the need for our #NSCLC assay.

https://t.co/eHrmBJdgiS

#genetics #oncology #leadership #dPCR

[ChromaCode, Inc. @chromacodeinc]

Our #HDPCR assay for #NSCLC has faster turn-around times compared to #NGS and more comprehensive results compared to standard #dPCR.

Check it out: https://t.co/uKInN8rMSJ

[ChromaCode, Inc. @chromacodeinc]

We’re proud to announce the publication of a study in the scientific journal Diagnostics demonstrating that our #HDPCR #NSCLC assay outperforms #NGS in cases where there is low sample input.

Learn more: https://t.co/o2KgDHYFH9

#Oncology #Innovation #Publication #Genetics

[ChromaCode, Inc. @chromacodeinc]

Don’t miss TODAY’S presentation by our CBO, Padma Sundar, who is speaking about using our #HDPCR assay for high TAM applications which might otherwise require #NGS, as part of @PMWCintl’s Showcase Track S2: Clinical Dx/Tools Track.

https://t.co/xIcmkhyh39

#PMWC24 #genomics

[ChromaCode, Inc. @chromacodeinc]

Our CBO, Padma Sundar, is speaking at @PMWCintl about using our #HDPCR assay as an alternative for high TAM applications for applications which might otherwise require #NGS, as part of the #PMWC24’s Showcase Track S2: Clinical Dx/Tools Track.

https://t.co/xIcmkhyh39

[ChromaCode, Inc. @chromacodeinc]

#MeetTheTeam – Crane Harris, our VP of corporate development, brings extensive experience working for #genomic companies to ChromaCode. He is passionate about developing #collaborations that allow us to further develop our #HDPCR technologies.

https://t.co/aHdBgUBQAK

[ChromaCode, Inc. @chromacodeinc]

Recently we announced the following changes to our Board of Directors:

➡Mark McDonough, ChromaCode CEO, was appointed Chairman
➡ Former Chair, Carol Gallagher, Pharm.D., retired from the board
➡ Michele Park, Ph.D., was appointed to the board

https://t.co/0jMux4ngCj

[ChromaCode, Inc. @chromacodeinc]

Our CEO, Mark McDonough, engaged in an insightful discussion with Jeff Harmon of 'Conversations Life Science Leaders Aren't Having' and @russopartners, shedding light on effective collaboration with investors.

#Biotech #Innovation #JPM2024 #Genomics

[Russo Partners @russopartners]

Watch Mark McDonough, CEO of @chromacodeinc on 'Conversations Life Science Leaders Aren't Having' discuss investor confidence in #BioTech at #JPM2024. Key insights on balancing tech innovation with smart finance.

#HealthcareInnovation #MarketInsights #JPM24